Evaluating Patient Participation in Clinical Trials for CLL and SLE in Germany-A Mixed-Methods Study on Enrollment Potential Based on Claims Data.

Autor: Kuschel AS; Vintura GmbH, Münchner Technologiezentrum, Agnes-Pockels-Bogen 1, 80992 Munich, Germany., Ernst R; Vintura GmbH, Münchner Technologiezentrum, Agnes-Pockels-Bogen 1, 80992 Munich, Germany., Beck JP; Vintura GmbH, Münchner Technologiezentrum, Agnes-Pockels-Bogen 1, 80992 Munich, Germany., Borchert K; Xcenda GmbH, Lange Laube 31, 30159 Hannover, Germany., Braun S; Xcenda GmbH, Lange Laube 31, 30159 Hannover, Germany., Ruppert T; VFA (German Association of Research-Based Pharmaceutical Companies), 10117 Berlin, Germany., Meergans M; VFA (German Association of Research-Based Pharmaceutical Companies), 10117 Berlin, Germany.

Publikováno v: Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2024 Oct 25; Vol. 12 (21). Date of Electronic Publication: 2024 Oct 25.

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)

Autor: Moehler, M., Maderer, A., Thuss-Patience, P.C., Brenner, B., Meiler, J., Ettrich, T.J., Hofheinz, R.-D., Al-Batran, S.E., Vogel, A., Mueller, L., Lutz, M.P., Lordick, F., Alsina, M., Borchert, K., Greil, R., Eisterer, W., Schad, A., Slotta-Huspenina, J., Van Cutsem, E., Lorenzen, S.

Publikováno v: In Annals of Oncology February 2020 31(2):228-235

Treatment with the SQ tree sublingual immunotherapy tablet is safe and well tolerated in real-life.

Autor: Pfaar O; Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany., Wolf H; Medical Department/Clinical Development, ALK-Abelló Arzneimittel GmbH, Hamburg, Germany., Reiber R; Facharztpraxis für HNO/Allergologie, Schorndorf, Germany., Knulst A; Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Sidenius K; Allergiklinikken i Bagsværd, Bagsværd, Denmark.; Aleris Hospitaler København, Søborg, Denmark., Mäkelä MJ; Skin and Allergy Hospital, HUS, Helsinki University Hospital, Helsinki, Finland., Steinsvåg S; Sørlandet Sykehus, Kristiansand, Norway., Janson C; Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden., van der Zwan L; ALK-Abelló Benelux, Almere, The Netherlands., Uss E; ALK-Abelló Benelux, Almere, The Netherlands., Arvidsson P; ALK Nordic A/S, Danmark filial, Kungsbacka, Sweden., Borchert K; Xcenda GmbH, part of Cencora, Hannover, Germany., Himmelhaus H; Xcenda GmbH, part of Cencora, Hannover, Germany., Wüstenberg E; Medical Department/Clinical Development, ALK-Abelló Arzneimittel GmbH, Hamburg, Germany.; Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine (and University Hospital) Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Publikováno v: Clinical and translational allergy [Clin Transl Allergy] 2024 Jul; Vol. 14 (7), pp. e12373.

Unemployment and online labor: Evidence from microtasking

Autor: Laitenberger, Ulrich, Viete, Steffen, Slivko, Olga, Kummer, Michael E., Borchert, K., Hirth, Matthias

Publikováno v: Management Information Systems Quarterly, 47(2), 771-802. Management Information Systems Research Center

We analyze the relationship between unemployment and the supply of online labor for microtasking. Using detailed US data from a large microtasking platform between 2011 and 2015, we study the participation and the number of hours supplied by workers

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::0ef3644e856fa6fda094849ba003e9ec
https://research.tilburguniversity.edu/en/publications/41b20090-6a5c-4556-9d43-a912ed5b8934

Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.

Autor: Schmoll HJ; Clinic for Internal Medicine IV-Hematology/Oncology, University Clinic, Martin-Luther-University, Halle-Wittenberg, Germany., Mann J; Department of Medicine, Hematology and BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Meinert F; Clinic for Internal Medicine IV-Hematology/Oncology, University Clinic, Martin-Luther-University, Halle-Wittenberg, Germany., Garlipp B; Department for Surgery, Oberhavel Kliniken Oranienburg, Oranienburg, Germany., Borchert K; Clinic for Oncology/Hematology Klinikum Magdeburg, Magdeburg, Germany., Vogel A; Clinic for Gastroenterology, Medical University Hannover, Hannover, Germany., Goekkurt E; Department of Medicine, Hematology and BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kaiser U; Clinic for Hematology/Oncology, St. Bernward Krankenhaus, Hildesheim, Germany., Hoeffkes HG; Tumorclinic, Klinikum Fulda, Fulda, Germany., Rüssel J; Clinic for Internal Medicine IV-Hematology/Oncology, University Clinic, Martin-Luther-University, Halle-Wittenberg, Germany., Kanzler S; Medical Clinic II, Leopoldina Clinic Schweinfurt, Schweinfurt, Germany., Edelmann T; Oncological Practice Schkeuditz, Schkeuditz, Germany., Forstbauer H; Oncological Practice Rheinsieg, Bonn, Germany., Göhler T; Oncological Center Dresden, Dresden, Germany., Hannig C; Oncological Practice Bottrop, Bottrop, Germany., Hildebrandt B; Clinic for Gastroenterology, Hematology and Medical Oncology, Klinikum Barnim, Eberswalde, Germany., Roll C; Clinic for Oncology/Hematology Klinikum Magdeburg, Magdeburg, Germany., Bokemeyer C; Department of Medicine, Hematology and BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Steighardt J; Coordination Center for Clinical Trials Halle, Medical Faculty, Martin-Luther-University, Halle-Wittenberg, Germany., Cygon F; Clinic for Internal Medicine IV-Hematology/Oncology, University Clinic, Martin-Luther-University, Halle-Wittenberg, Germany., Ibach S; X-act Cologne Clinical Research GmbH, Köln, Germany., Stein A; Department of Medicine, Hematology and BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Tintelnot J; Department of Medicine, Hematology and BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. j.tintelnot@uke.de.

Publikováno v: British journal of cancer [Br J Cancer] 2024 Feb; Vol. 130 (2), pp. 233-241. Date of Electronic Publication: 2023 Nov 23.